Nguyen D H
Abteilung für Allgemeine Physiologie, Universität Ulm, Germany.
Arzneimittelforschung. 1997 Dec;47(12):1351-8.
The aim of this study was to provide evidence supporting the hypothesis that the reactivity of the vascular smooth muscle (VSM) cell is controlled at the cell membrane level by adenosine triphosphate (ATP)-sensitive (KATP) K channels, acting as signal amplifying modulators of the function of L-type voltage operated Ca channels. KATP channels, detected in numerous parts of the vascular tree, are targets for extracellular ATP or adenosine, which stimulate A2 receptors mediating relaxation. To test the hypothesis of a putative role for KATP channels switching between vasoconstricting and vasodilating mechanisms, changes in contractile reactivity were measured in helical strips of epicardial porcine coronary artery preparations in response to various vasoconstrictor and vasodilator substances or combination of these. The data show that the tonic component of the biphasic contractions induced by several agonists (acetylcholine, histamine, serotonin), as well as the contractions induced by F- ions (2 mmol/l), which activate G proteins downstream of the receptors could be inhibited by both adenine nucleotides and by cromakalim, known as openers of KATP channels. The EC50 values for the dose-response curves established for the inhibition of histamine-induced contractions by adenosine were nearly identical to those obtained for the relaxations of fluoride-induced contractions by cromakalim: resp. 0.556 +/- 0.081 and 0.590 +/- 0.052 mumol/l (n = 6). Contractions induced by BAY k 8644 (20 nmol/l), by tetraethylammonium (5 mmol/l) or by beta-methyldigoxin (1 mumol/l) were also strongly inhibited by 1 mumol/l cromakalim. From the results obtained in this study, it may be concluded that KATP channels could possibly play an integrative role in the signal transduction mechanism in VSM in that they act as common effectors for both vasoconstrictor and vasodilator agonists.
血管平滑肌(VSM)细胞的反应性在细胞膜水平受三磷酸腺苷(ATP)敏感性(KATP)钾通道控制,该通道作为L型电压门控钙通道功能的信号放大调节剂。在血管树的许多部位检测到的KATP通道是细胞外ATP或腺苷的作用靶点,它们刺激介导舒张的A2受体。为了检验KATP通道在血管收缩和舒张机制之间切换的假定作用假说,在猪心外膜冠状动脉螺旋条制备物中测量了收缩反应性的变化,以响应各种血管收缩剂和血管舒张剂物质或它们的组合。数据表明,几种激动剂(乙酰胆碱、组胺、5-羟色胺)诱导的双相收缩的张力成分,以及由F-离子(2 mmol/l)诱导的收缩(激活受体下游的G蛋白),均可被腺嘌呤核苷酸和克罗卡林(已知的KATP通道开放剂)抑制。腺苷抑制组胺诱导收缩的剂量反应曲线的EC50值与克罗卡林舒张氟诱导收缩的EC50值几乎相同:分别为0.556±0.081和0.590±0.052 μmol/l(n = 6)。1 μmol/l克罗卡林也强烈抑制BAY k 8644(20 nmol/l)、四乙铵(5 mmol/l)或β-甲基地高辛(1 μmol/l)诱导的收缩。从本研究获得的结果可以得出结论,KATP通道可能在VSM的信号转导机制中发挥整合作用,因为它们是血管收缩剂和血管舒张剂激动剂的共同效应器。